NIH Funds Research Into Self-Disseminating Vaccines That Spread Like a Virus from Host to Host
$3.4 million in U.S. taxpayer money to self-spreading vaccine projects.
In a startling revelation, the U.S. National Institutes of Health (NIH) has been funneling millions of American taxpayer dollars into self-spreading vaccine research for nearly a decade.
Follow Jon Fleetwood: Instagram @realjonfleetwood / Twitter @JonMFleetwood / Facebook @realjonfleetwood
NIH collaborations with the University of Idaho and Pennsylvania State University total $3,376,453 in U.S. taxpayer funding.
Self-disseminating vaccines are made of genetically engineered viruses designed to move through populations in the same way infectious diseases do.
Self-spreading vaccines are considered unethical and illegal by some because they are not only largely untested and lack long-term safety data, but they violate the individual’s right to informed consent and to deny medical treatment.
Individuals could be vaccinated without their consent.
The news follows recent congressional confirmation that NIH, through EcoHealth Alliance, funded dangerous gain-of-function research on the very SARS-CoV2 virus that brought about the COVID-19 pandemic.
It also follows this website’s Christmas Eve report showing EcoHealth’s ‘DEFUSE’ project submitted in 2018 to DARPA that outlined plans to engineer coronaviruses entailed using drones to spray self-spreading COVID vaccines on humans.
A growing body of evidence suggests the COVID pandemic virus wasn’t merely a virus cooked up in a biolab, but a virus-vaccine designed to spread from host to host.
Moreover, the DEFUSE submission claimed bats were the project’s target vectors.
But Congress, the Department of Energy, the FBI, and other intelligence agencies believe engineered COVID viruses, like those proposed by DEFUSE, are what killed over a million Americans.
Questions are raised as to whether they were really killed by a self-spreading COVID vaccine.
NIH Funds Self-Spreading Vaccine Projects with University of Idaho
According to the Tracking Accountability in Government Grants System (TAGGS), NIH has awarded (archive) the University of Idaho more than $1.7 million for a project titled “A Mathematical Theory of Transmissible Vaccines” under award number R01GM122079.
The funding goes all the way back to 2016, when Moderna patented a spike protein genetic sequence for its COVID-19 vaccine.
TAGGS is a database of grants awarded by the twelve Operating Divisions (OPDIVs) of the Department of Health and Human Services (HHS), according to the government website.
“TAGGS tracks obligated grant funds at the transaction level” and represents “a robust reporting tool developed by the HHS Office of Grants,” the website reads.
The award is from the National Institute of General Medical Sciences (NIGMS), which is one of the institutes within NIH.
According to the award abstract, scientists aim to engineer transmissible vaccines using murine cytomegalovirus to eliminate pathogens in animal reservoirs, reducing spillover risks to humans.
It reads:
Each year, millions of people are harmed or killed by pathogens that spill over from wild or domestic animal reservoirs. A new approach to reducing the threat of spillover is to eliminate the pathogen from its animal reservoir using transmissible vaccines that move from animal to animal providing immunity to the pathogen as they go. Transmissible vaccines reduce the vaccination effort required for pathogen control within animal reservoirs and allow the vaccine to penetrate remote reservoir habitats where direct vaccination is impossible. Bringing this revolutionary idea to fruition requires that we engineer vaccines that simultaneously: 1) transmit efficiently from animal to animal, 2) stimulate a robust immune response to the target pathogen, and 3) maintain their integrity in the face of evolutionary pressures. This project will develop mathematical models that predict how these traits of the vaccine emerge from the interplay between vaccine replication and the animal’s immune response. These models will be parameterized and validated using laboratory studies of prototype transmissible vaccines that use murine cytomegalovirus (MCMV) as a vector backbone. We focus on MCMV as a vector because it is highly species specific, capable of superinfection, and provides a model for vaccine development across murine rodents that serve as important reservoirs for a wide range of human pathogens. The models will be validated using experiments with immune depleted mice that challenge their ability to explain both pattern and process. Work on this project capitalizes on an existing collaboration between experts in mathematical modeling, viral evolution, and murine cytomegalovirus.
At least four publications in the U.S. National Library of Medicine (NLM) show the University of Idaho has been actively working on self-disseminating vaccines (here, here, here, here).
NIH Funds Self-Spreading Vaccine Projects with Pennsylvania State University
The TAGGS website shows (archive) NIH has also funded Pennsylvania State University over $1.6 million for a project titled “US-UK Collab: The consequences of transmissible vaccines on disease ecology and pathogen evolution: Marek’s disease virus as a case study” (R01GM140459).
The award abstract explains the “risk” of self-spreading vaccines, and how they are “capable of disseminating from vaccinated to non-vaccinated hosts.”
This NIH-funded research will study how a chicken vaccine spreads between birds and how this might affect the disease it’s meant to prevent, including the risk of the vaccine itself changing and becoming harmful, according to the award abstract.
It reads:
Vaccination can be one of the most efficient and effective tools for controlling infectious diseases, but in many settings, including wildlife and farm animal diseases, logistical and economic hurdles make it impractical to vaccinate large enough fractions of hosts to achieve herd immunity. Transmissible vaccines, defined as vaccines capable of disseminating from vaccinated to non-vaccinated hosts, offer one potential solution to these challenges by amplifying the impact of vaccination campaigns. However, transmissible vaccines are not without risk. Reversion to virulence or recombination with wildtype pathogens could cause transmissible vaccines to make matters worse or complicate elimination efforts. This proposed work will for the first time quantify the effects of transmissible vaccines on disease ecology and evolution using an economically important, naturally transmissible vaccine currently in widespread use on poultry farms. Marek’s disease, a poultry-specific disease that is a threat to sustainable poultry production, is currently controlled by the “Rispens” vaccine, a live, attenuated vaccine that has been widely used for two decades. Recent experiments have found that this vaccine is capable of efficiently transmitting from vaccinated to non-vaccinated birds. These results are consistent with recent field surveillance studies that have found vaccine isolates in cohorts that have not been directly vaccinated. In addition, advances in whole genome sequencing have revealed recombination between the vaccine virus and the wildtype virus, which is concerning given that the vaccine virus harbors highly virulent forms of the oncogenic meq gene. Together, these observations demonstrate that the Rispens vaccine is a transmissible vaccine capable of evolving and potentially facilitating adverse evolution of wildtype Marek’s disease virus. Our primary objective is to quantify the consequences of transmissible vaccine use. Specifically, we will: 1) Develop a general model of transmissible vaccination to identify key knowledge gaps, 2) Characterize vaccine transmission and its impact on wildtype virus transmission, 3) Characterize the genetic evolution of wildtype virus and vaccine virus, 4) Model the overall impact of Rispens vaccination on Marek’s disease virus and its vaccine
The news of NIH funding self-spreading chicken vaccine technology comes as mainstream authorities claim an H5N1 avian influenza “bird flu” pandemic is on the horizon.
The U.S. government and Bill Gates both have been funding bird flu virus gain-of-function research and bird flu vaccine development: the problem and the solution.
Alarmingly, the new U.S. spending bill hides an extension on government emergency powers—like those used during the COVID pandemic—through March 2025.
With the deadliest pandemic in recent history originating in pathogen gain-of-function experiments and vaccine development, some are asking at what point such endeavors cross the line from dual-use bioweapons/countermeasure creation into bioterrorism.
Follow Jon Fleetwood: Instagram @realjonfleetwood / Twitter @JonMFleetwood / Facebook @realjonfleetwood
New 116-Page Stop-Gap Bill Hides Renewed Emergency Powers Extended to 2025
Summary: The shorter, 116-page version of the 1,547-page stop-gap spending bill unveiled Tuesday night includes provisions that quietly extend government emergency powers under the Public Health Service Act (PHSA) (here) to March 31, 2025. Notably, the bill does not specify what these sections entail—an alarming omission given the sweeping powers they g…
California Declares Bird Flu State of Emergency
California Governor Gavin Newsom today proclaimed a State of Emergency in response to H5N1 avian influenza “bird flu,” following dozens of reports from this website warning readers of a potentially incoming, orchestrated H5N1 avian influenza pandemic.
California NIH/Bill Gates-Funded BSL-3 Biolab Mutates H5N1 Bird Flu Virus with Gain-of Function Experiments: Journal 'Science'
A new research article published last week in Science reveals that scientists at Scripps Research in California are performing risky gain-of-function experiments on H5N1 avian influenza viruses to make them more dangerous to humans, potentially causing another pandemic.
FDA Greenlights New Bill Gates-Funded ARCT-2304 Self-Replicating samRNA 'Pandemic' H5N1 Bird Flu Jab
Arcturus Therapeutics, a company specializing in mRNA-based pharmaceuticals, quietly announced Monday that the U.S. Food and Drug Administration (FDA) has granted approval for its Investigational New Drug (IND) application for ARCT-2304, a self-amplifying mRNA (sa-mRNA) injection targeting the H5N1 avian influenza “bird flu” virus.
U.S. Gov't Is Making a Vaccine for a Virus It Also Happens to Be Making More Deadly: Bird Flu
The U.S. Department of Agriculture (USDA) is spending $1 million of American taxpayer money to fund gain-of-function experiments on dangerous bird flu (avian influenza) viruses in collaboration with Chinese scientists, according to a new report.
Australia Makes $1 Billion Bet On Coming H5N1 Pandemic, Creates Bird Flu Task Force
The Australian government has unveiled a massive $1 billion biosecurity investment to prepare for potential outbreaks of the H5N1 bird flu, a strain it says poses “significant risks” to the nation’s industry, trade, and wildlife.
Bill Gates Isn't the Largest Funder of His Global Vaccine Campaign—American Taxpayers Are
Though many believe globalist Bill Gates funds his international vaccination campaign himself, recent White House announcements reveal the American people are the largest financial backers of his Gavi vaccine agenda, contributing over $11.5 billion through taxpayer-funded government allocations.
Congress to Fund New Biolab Construction, Deadly Pathogen Research, Coming Influenza Pandemic, Vaccines: Speaker Johnson’s New 1,500-Page Spending Bill
In a new spending bill first seen last night, the United States government is looking to bankroll the construction of new biolabs, risky experiments on dangerous pathogens, vaccines, and the coordination of an apparently incoming influenza pandemic.
Quoted from the article: "This proposed work will for the first time quantify the effects of transmissible vaccines on disease ecology and evolution using an economically important, naturally transmissible vaccine currently in widespread use on poultry farms."
Problem (an invented problem). Reaction (Lie about the cause of the problem). Solution (Make sure the solution is "economically" important). Rinse and repeat...
All these assholes need to hang.
Norovirus (I was a victim this past weekend until Monday) is sweeping through the US and is highly contagious. It's quite horrible. I hope its effects are not long lasting. They aren't supposed to be. Many people I talk to across the country and definitely locally have it or had it.
here's some info. The CDC says that anyone can get infected and become sick with norovirus, and people of all ages can get infected during norovirus outbreaks.
Majority of norovirus outbreaks occur when infected individuals spread the virus to other via direct contact, says the CDC. This can happen when caring for infected individuals, as well as by sharing food or eating utensils. Surfaces that have been contaminated with the norovirus, including food and water, can lead to outbreaks.
I wonder if it's being purposely spread. It works better than a lock down to keep people home.